Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,610.00    48.50 (1.06%)
Bid:
4,609.50
Ask:
4,610.50
Spread: 1.00 (0.022%)
Market Cap: £99.27b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Share Buy-Back Programme

17 May 2024 07:00

RNS Number : 8168O
Unilever PLC
17 May 2024
 

Commencement of Share Buyback Programme

 

London - Unilever PLC announces the commencement of its up to €1.5 billion share buyback

 

With our full year 2023 results on 8 February 2024, Unilever PLC announced a programme to buy back shares with an aggregate market value equivalent of up to €1.5 billion to be conducted during 2024 (the "Programme").

 

The first tranche of the Programme (the "First Tranche") will be for an aggregate market value equivalent of up to €850 million which will be bought back in the form of Unilever PLC ordinary shares.

 

The First Tranche will commence on 17 May 2024 and will end on or before 30 August 2024. The purpose of the First Tranche is to reduce the capital of Unilever PLC and it will take place within the limitations of the authority granted to the Board of Unilever PLC by its general meeting, held on 1 May 2024, pursuant to which the maximum number of shares to be bought back by Unilever PLC is 250,200,000.

 

Unilever PLC has entered into non-discretionary instructions with Goldman Sachs International to conduct the First Tranche on its behalf and to make trading decisions under the First Tranche independently of Unilever PLC.

 

ENDS

 

Enquiries

 

Media:

Unilever Press Office

press-office.london@unilever.com

 

Investors:

Investor Relations Team investor.relations@unilever.com

 

 

About Unilever

Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Nutrition and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €59.6 billion in 2023.

 

For more information about Unilever and our brands, please visit www.unilever.com.

 

 

Notes to editors

 

Important information

This announcement contains inside information. This is a public announcement pursuant to Article 17 Paragraph 1 of the European Market Abuse Regulation (596/2014), including as it forms part of UK law.

 

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995, including with relation to Unilever's share buyback programme, its purpose and timetable. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'seek', 'continue', 'projected', 'estimate', 'achieve' or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements.

 

Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. Forward-looking statements are not predictions of future events. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us.

 

These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2023 and the Unilever Annual Report and Accounts 2023 available on our corporate website www.unilever.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBCGDUDSBDGSL
Date   Source Headline
5th Sep 202311:21 amRNSDirector/PDMR Shareholding
1st Sep 20232:47 pmRNSDirector/PDMR Shareholding
1st Sep 20232:45 pmRNSTotal Voting Rights
10th Aug 20234:12 pmRNSDirector/PDMR Shareholding
2nd Aug 20232:00 pmRNSCancellation of Treasury Shares
1st Aug 202311:27 amRNSTotal Voting Rights
1st Aug 202310:15 amRNSDirector/PDMR Shareholding - Replacement
1st Aug 202310:09 amRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSUnilever PLC Announces Directorate Change
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20233:02 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:33 pmRNSTotal Voting Rights
30th Jun 202310:10 amRNSBlock listing Six Monthly Return
20th Jun 20234:26 pmRNSDirector/PDMR Shareholding
16th Jun 20235:54 pmRNSDirector/PDMR Shareholding
9th Jun 202311:51 amRNSDirector/PDMR Shareholding
6th Jun 202311:46 amRNSDirector/PDMR Shareholding
5th Jun 20235:31 pmRNSShare Buyback Programme Update
2nd Jun 20234:57 pmRNSTransaction in Own Shares
1st Jun 20235:07 pmRNSTransaction in Own Shares
1st Jun 20234:22 pmRNSTotal Voting Rights
31st May 20234:58 pmRNSTransaction in Own Shares
30th May 20234:57 pmRNSTransaction in Own Shares
30th May 20237:00 amRNSDirectorate Change
26th May 20234:54 pmRNSTransaction in Own Shares
25th May 20234:48 pmRNSTransaction in Own Shares
25th May 20232:48 pmRNSPublication of Financial Statements for UFN
25th May 202311:23 amRNSDirector/PDMR Shareholding
24th May 20234:54 pmRNSTransaction in Own Shares
23rd May 20234:43 pmRNSTransaction in Own Shares
23rd May 20234:20 pmRNSDirector/PDMR Shareholding
22nd May 20234:48 pmRNSTransaction in Own Shares
19th May 20234:53 pmRNSTransaction in Own Shares
18th May 20234:48 pmRNSTransaction in Own Shares
18th May 20232:52 pmRNSDirector/PDMR Shareholding
17th May 20234:53 pmRNSTransaction in Own Shares
16th May 20234:55 pmRNSTransaction in Own Shares
15th May 20234:56 pmRNSTransaction in Own Shares
12th May 20234:55 pmRNSTransaction in Own Shares
11th May 20234:53 pmRNSTransaction in Own Shares
10th May 20234:54 pmRNSTransaction in Own Shares
9th May 20234:55 pmRNSTransaction in Own Shares
5th May 20234:50 pmRNSTransaction in Own Shares
4th May 20235:02 pmRNSTransaction in Own Shares
3rd May 20234:56 pmRNSTransaction in Own Shares
3rd May 20234:49 pmRNSConfirmation of Board Committee Membership
3rd May 20234:33 pmRNSResult of AGM
2nd May 20234:52 pmRNSTransaction in Own Shares
2nd May 202312:02 pmRNSTotal Voting Rights
28th Apr 20234:53 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.